# 🧬 WIA-AUG-017: Longevity Gene Editing Standard

[![Version](https://img.shields.io/badge/version-1.0.0-blue.svg)]()
[![License](https://img.shields.io/badge/license-MIT-green.svg)]()
[![Standard](https://img.shields.io/badge/WIA-Standard-purple.svg)]()


> **Standard ID:** WIA-AUG-017
> **Version:** 1.0.0
> **Status:** Active
> **Category:** Human Augmentation / Bionics
> **Color:** Cyan (#06B6D4)

---

## 🌟 Overview

The WIA-AUG-017 standard defines comprehensive protocols for longevity gene editing technologies, including target gene selection, editing methodologies, delivery mechanisms, safety protocols, efficacy metrics, and ethical frameworks for extending human healthspan and lifespan.

**홍익인간 (弘益人間) - Benefit All Humanity** - This standard aims to ensure that longevity gene editing technologies are developed and deployed safely, ethically, and effectively, enabling the extension of healthy human life while protecting individuals and future generations.

## 🎯 Key Features

- **Target Gene Database**: Comprehensive catalog of longevity-associated genes
- **Editing Technologies**: Standards for CRISPR, base editing, prime editing, and epigenetic modification
- **Delivery Mechanisms**: Protocols for viral vectors, lipid nanoparticles, and other delivery methods
- **Aging Biomarkers**: Standardized measurement of epigenetic age, telomere length, and senescence markers
- **Safety Protocols**: Off-target detection, monitoring, and reversibility procedures
- **Efficacy Metrics**: Validated measures of biological age reduction and healthspan extension
- **Ethical Framework**: Consent, equity, and long-term population considerations

## 📊 Core Concepts

### 1. Longevity Target Genes

```
Telomere Regulation: TERT, TERC
Metabolic Pathways: SIRT1, SIRT3, SIRT6, AMPK, MTOR
Stress Response: FOXO3, NRF2
Growth Factors: GDF11, KLOTHO
DNA Repair: BRCA1, TP53
Lipid Metabolism: APOE, CETP
```

### 2. Editing Technologies

```
CRISPR-Cas9: Double-strand break repair
Base Editing: Direct nucleotide conversion
Prime Editing: Precise insertions/deletions
Epigenetic Modification: DNA methylation, histone modification
RNA Interference: Gene expression suppression
```

### 3. Biological Age Assessment

```
Biological Age = f(Epigenetic Clock, Telomere Length, Senescent Cells, Biomarkers)
```

Where:
- `Epigenetic Clock` = DNA methylation pattern analysis (Horvath, Hannum, GrimAge clocks)
- `Telomere Length` = Average telomere length across cell populations
- `Senescent Cells` = Percentage of senescent cells (p16, p21 markers)
- `Biomarkers` = Inflammation, metabolic, and functional markers

### 4. Healthspan Extension Calculation

```
Healthspan Extension = (Post-Edit Biological Age - Post-Edit Chronological Age) -
                       (Pre-Edit Biological Age - Pre-Edit Chronological Age)
```

## 🔧 Components

### TypeScript SDK

```typescript
import {
  assessBiologicalAge,
  selectTargetGenes,
  designEditingProtocol,
  evaluateOffTarget,
  monitorEfficacy,
  trackHealthspan
} from '@wia/aug-017';

// Assess baseline biological age
const bioAge = assessBiologicalAge({
  epigeneticAge: 52.3,
  telomereLength: 6.8, // kb
  senescentCells: 12.5, // %
  inflammationMarkers: { crp: 2.1, il6: 3.4 }
});

// Select optimal target genes
const targets = selectTargetGenes({
  age: 45,
  goals: ['healthspan', 'metabolic_health'],
  riskTolerance: 'moderate'
});

// Design editing protocol
const protocol = designEditingProtocol({
  targetGenes: ['TERT', 'FOXO3', 'SIRT6'],
  editingTech: 'base_editing',
  deliveryMethod: 'AAV_vector',
  tissueTargets: ['liver', 'muscle', 'adipose']
});

console.log(bioAge.biologicalAge, targets.recommendedGenes);
console.log(protocol.editingSteps, protocol.safetyChecks);
```

### CLI Tool

```bash
# Assess biological age
wia-aug-017 assess-age --epigenetic 52.3 --telomere 6.8 --senescent 12.5

# Select target genes
wia-aug-017 select-genes --age 45 --goals healthspan,metabolic --risk moderate

# Design editing protocol
wia-aug-017 design-protocol --genes TERT,FOXO3,SIRT6 --tech base_editing

# Evaluate off-target effects
wia-aug-017 off-target --guide-rna GCTAGCTGATCG --genome hg38

# Monitor efficacy
wia-aug-017 monitor --patient-id PT-12345 --interval 3months

# Track healthspan
wia-aug-017 healthspan --patient-id PT-12345 --duration 2years
```

## 📚 Documentation

| Document | Description |
|----------|-------------|
| [WIA-AUG-017-v1.0.md](./spec/WIA-AUG-017-v1.0.md) | Complete specification with protocols |
| [TypeScript SDK](./api/typescript/) | Full TypeScript implementation |
| [CLI Tool](./cli/wia-aug-017.sh) | Command-line interface |

## 🚀 Quick Start

### Installation

```bash
# Clone repository
git clone https://github.com/WIA-Official/wia-standards.git
cd wia-standards/standards/longevity-gene

# Run installation script
./install.sh

# Verify installation
wia-aug-017 --version
```

### TypeScript Usage

```bash
# Install via npm
npm install @wia/aug-017

# Or yarn
yarn add @wia/aug-017
```

```typescript
import { LongevityGeneEditingSDK } from '@wia/aug-017';

const sdk = new LongevityGeneEditingSDK();

// Perform comprehensive longevity assessment
const assessment = sdk.assessLongevity({
  patient: {
    age: 45,
    gender: 'female',
    healthStatus: 'good',
    familyHistory: ['cardiovascular', 'alzheimers']
  },
  biomarkers: {
    epigeneticAge: 52.3,
    telomereLength: 6.8,
    senescentCells: 12.5,
    crp: 2.1,
    il6: 3.4,
    glucoseFasting: 98
  }
});

console.log(`Biological Age: ${assessment.biologicalAge}`);
console.log(`Age Acceleration: ${assessment.ageAcceleration} years`);
console.log(`Recommended Targets: ${assessment.recommendedTargets.join(', ')}`);
console.log(`Expected Healthspan Extension: ${assessment.projectedHealthspanGain} years`);
```

## 🧬 Target Gene Categories

| Category | Genes | Primary Function | Evidence Level |
|----------|-------|------------------|----------------|
| Telomere Maintenance | TERT, TERC, RTEL1 | Telomerase activity | Strong |
| Sirtuins | SIRT1, SIRT3, SIRT6 | NAD+ metabolism, stress response | Strong |
| Metabolic Regulation | AMPK, MTOR, FOXO3 | Energy sensing, autophagy | Strong |
| Growth Factors | GDF11, KLOTHO | Cellular rejuvenation | Moderate |
| DNA Repair | BRCA1, TP53, ATM | Genome stability | Strong |
| Lipid Metabolism | APOE, CETP, PCSK9 | Cardiovascular health | Strong |
| Inflammation | IL6, TNF, NLRP3 | Inflammaging reduction | Moderate |
| Mitochondrial | TFAM, PGC1A, NRF1 | Mitochondrial biogenesis | Moderate |

## ⚙️ Editing Technologies

| Technology | Precision | Efficiency | Off-Target Risk | Reversibility |
|------------|-----------|------------|-----------------|---------------|
| CRISPR-Cas9 | Moderate | High | Moderate | Low |
| Base Editing | High | Moderate-High | Low | Low |
| Prime Editing | Very High | Moderate | Very Low | Low |
| Epigenetic Modification | Moderate | High | Low | Moderate |
| RNA Interference | N/A | High | Moderate | High |

## ⚠️ Safety Considerations

1. **Off-Target Effects**: Comprehensive genome-wide screening required (WGS + computational prediction)
2. **Germline Editing**: Strictly prohibited unless specifically approved by ethics board
3. **Cancer Risk**: Mandatory monitoring of cell proliferation markers (p53, telomerase activity)
4. **Immune Response**: HLA typing and immunosuppression protocols
5. **Long-term Monitoring**: Minimum 10-year longitudinal follow-up
6. **Reversibility**: Documented reversal protocols for epigenetic modifications
7. **Equity**: Accessibility frameworks to prevent longevity inequality
8. **Informed Consent**: Enhanced consent procedures with generational implications

## 📈 Efficacy Metrics

### Primary Outcomes
- **Biological Age Reduction**: Δ Epigenetic Age (Horvath, GrimAge clocks)
- **Telomere Elongation**: Mean telomere length increase (>0.5 kb significant)
- **Senescent Cell Clearance**: Reduction in p16+ cells (>30% target)

### Secondary Outcomes
- **Healthspan Extension**: Years of disability-free life
- **Biomarker Improvement**: CRP, IL-6, glucose, lipid profiles
- **Functional Capacity**: VO2 max, grip strength, cognitive function
- **Disease Incidence**: Age-related disease onset delay

### Safety Outcomes
- **Off-Target Editing**: <0.1% genome-wide
- **Adverse Events**: Grade 3+ events <5%
- **Cancer Incidence**: Not exceeding age-matched controls

## 🌐 WIA Integration

This standard integrates with:
- **WIA-AUG-001**: Human Augmentation General Standards
- **WIA-AUG-013**: Augmentation Safety
- **WIA-AUG-014**: Human-Machine Interface (for monitoring devices)
- **WIA-BIO**: Bioethics and Biosafety Standards
- **WIA-GEN**: Genomics and Gene Therapy Standards
- **WIA-MED**: Medical Device Standards

## 📖 Use Cases

1. **Preventive Healthspan Extension**: Healthy individuals seeking to extend disability-free years
2. **Age-Related Disease Prevention**: Targeting genes associated with Alzheimer's, cardiovascular disease
3. **Accelerated Aging Syndromes**: Treatment of progeria and Werner syndrome
4. **Healthspan Recovery**: Post-disease recovery and metabolic reset
5. **Research**: Longevity biomarker discovery and validation

## 🔬 Ethical Framework

### Core Principles
1. **Autonomy**: Informed consent with understanding of uncertainties
2. **Beneficence**: Maximize healthspan, minimize harm
3. **Non-maleficence**: Rigorous safety testing, long-term monitoring
4. **Justice**: Equitable access, prevent longevity divide
5. **Future Generations**: Consider hereditable implications

### Requirements
- **Ethics Board Approval**: Mandatory for all gene editing protocols
- **Equity Access Fund**: Portion of revenues for underserved populations
- **Transgenerational Monitoring**: Multi-generational safety surveillance
- **Right to Reverse**: Where technically feasible

## 🤝 Contributing

Contributions welcome! Please see our [Contributing Guide](https://github.com/WIA-Official/wia-standards/CONTRIBUTING.md).

## 📄 License

MIT License - see [LICENSE](https://github.com/WIA-Official/wia-standards/LICENSE)

## 🔗 Links

- **Website**: [wiastandards.com](https://wiastandards.com)
- **GitHub**: [github.com/WIA-Official/wia-standards](https://github.com/WIA-Official/wia-standards)
- **Documentation**: [docs.wiastandards.com](https://docs.wiastandards.com)
- **Certification**: [cert.wiastandards.com](https://cert.wiastandards.com)

---

**홍익인간 (弘益人間) · Benefit All Humanity**

*WIA - World Certification Industry Association*
*© 2025 SmileStory Inc. / WIA*
*MIT License*

---

**홍익인간 (弘益人間) - Benefit All Humanity** 🌍
